Dishman Pharmaceuticals plan to raise up to Rs 200 crore through QIP

     

      Dishman Pharmaceuticals & Chemicals has received an approval to raise up to Rs 200 crore by way of issue of shares to Qualified Institutional Investors (QIP), subject to approval of members. The board of directors at its meeting held on August 13, 2014 has approved for the same.
     Dishman Pharmaceuticals is engaged in the manufacturing of active pharmaceutical ingredients (APIs) intermediates. The Company operates in two segments contract reseach and contract manufacturing (CRAMS), and bulk drugs, intermediates, quats and specialty chemicals.
     The promoters holding in the company stood at 61.40% while Institutions and Non-Institutions held 14.75% and 23.85% respectively.
     The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 159.80 on 22-Jul-2014 and a 52 week low of Rs 39.65 on 28-Aug-2013.
     The stock current  price is Rs 129.00 up by 0.75 points from its previous closing of Rs 128.25